Blog

August 9, 2019
By: Michael Gomes, CEO, ClearHealth Quality Institute

The rise in adoption of telemedicine has generated an increased focus on the technology, its benefits, its challenges, and its outcomes. However, a number of stakeholders continue to be skeptical about the value of telemedicine in terms of its ability to produce clinical and financial outcomes equal to, or better than, face-to-face provider/patient encounters.

accreditation
patient outcomes
telemedicine
Read More »
July 30, 2019
By: Michael Gomes, CEO, ClearHealth Quality Institute

Although the concept of parity is straightforward in the abstract, it has proven to be extremely challenging for multiple state and federal regulators to develop and consistently apply a clear methodology for comparing all functions of modern managed care organizations. This is where accreditation can help.

accreditation
Mental Health Parity
MHPAEA
ParityManager
Read More »
July 9, 2019
By: Michael Gomes, CEO, ClearHealth Quality Institute

CHQI is not the only organization to turn its focus towards the importance of measuring telemedicine outcomes – the industry as a whole echoes our sentiment.

accreditation
ATA
CTeL
patient outcomes
telemedicine
Read More »
June 18, 2019
By: Michael Gomes, CEO, ClearHealth Quality Institute

Telehealth shows special promise to benefit patients, families and providers for treatment of substance use disorder (SUD), including opioid addiction.

Medicaid
reimbursement
Substance Use Disorder
telemedicine
Read More »
May 14, 2019
By: Michael Gomes, CEO, ClearHealth Quality Institute

Last month, The U.S. Centers for Medicare & Medicaid Services (CMS) finalized its plan to expand telehealth access and coverage in Medicare Advantage (MA) plans. There’s good news for MA plans, their members and providers: plans will be able to expand telehealth access and coverage beginning with plan year 2020 under a final rule published on April 5, 2019.

CMS
Medicare
reimbursement
telemedicine
Read More »
1 2 3 7